← All stocks

Bausch Health Companies Inc.

BHC No buying or selling
CIK 0000885590 #1855 in the set updated 22 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

19 insiders · 0 transactions
13.1×

Thomas J. Appio holds 13.1 times base salary in stock. $16.28M of shares against $1.24M in salary for 2025.

Salary from the company's own proxy. The shares are what Thomas J. Appio last reported holding, valued at $7.03, the price Common Shares, No Par Value was last bought or sold at on the open market here, on 19 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
PAULSON & CO. INC. entity
10% owner
73,255,869
$514.99M
+3.5%
Paulson John
Director
71,186,111
$500.44M
+166.7%
APPIO THOMAS
Chief Executive Officer
2,315,374
$16.28M
+70.9%
Charhon Jean-Jacques
EVP, CFO
706,478
$4.97M
+136.4%
Carson Seana
EVP, General Counsel
616,761
$4.34M
+41.7%
Lenar Aimee J.
President, US Pharma
334,853
$2.35M
+132.0%
WECHSLER AMY B
Director
314,979
$2.21M
+52.7%
POWER ROBERT N
Director
300,594
$2.11M
+50.0%
KAVANAGH SARAH B
Director
282,230
$1.98M
+55.1%
Miller Steven D
Director
229,224
$1.61M
+31.1%
ICAHN BRETT
Director
220,280
$1.55M
+48.2%
Barresi John S
SVP, Controller & CAO
192,268
$1.35M
+27.8%
Mulligan Richard
Director
155,616
$1.09M
+53.7%
Garcia Christian A
Director
135,578
$953.11K
+283.4%
LEUNG SANDRA
Director
97,070
$682.40K
Lee Frank D.
Director
95,210
$669.33K
+169.3%
GOETTLER MICHAEL
Director
76,020
$534.42K
LEE STEVEN HYOSIG
SVP, Controller & CAO
70,114
$492.90K
ROBERTS EIRY
Director
45,871
$322.47K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 4 Oct 2016